Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

Investor Relations

FINANCIAL INFORMATION

Financial Information

Here you will find a summary of Stemline Therapeutics's latest financial information.

Form	Filing date	View
10-Q	Nov 08, 2018	0001104659-18-066974.pdf EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
10-Q	Aug 09, 2018	0001104659-18-050944.pdf EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Form	Filing date	View
10-K	Mar 16, 2018	0001104659-18-018361.pdf EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Form	Filing date	View
DEFA14A	Apr 30, 2018	0001104659-18-028136.pdf View HTML